Anti-IgE Therapy Found Safe and Effective for Chronic Urticaria Anti-IgE Therapy Found Safe and Effective for Chronic Urticaria

Both doses of ligelizumab evaluated met the primary endpoint of superiority to placebo for a complete response at 16 weeks of therapy.MDedge News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Dermatology News Source Type: news